These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 31105570)

  • 21. Delivery systems for the direct application of siRNAs to induce RNA interference (RNAi) in vivo.
    Aigner A
    J Biomed Biotechnol; 2006; 2006(4):71659. PubMed ID: 17057369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of polymers for short interfering RNA delivery in vascular smooth muscle cells.
    Bools LM; Fisher RK; Grandas OH; Kirkpatrick SS; Arnold JD; Goldman MH; Freeman MB; Mountain DJ
    J Surg Res; 2015 Nov; 199(1):266-73. PubMed ID: 26272685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic SiRNA Delivery: Progress and Prospects.
    Roberts TC; Ezzat K; El Andaloussi S; Weinberg MS
    Methods Mol Biol; 2016; 1364():291-310. PubMed ID: 26472459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs.
    Kim EJ; Shim G; Kim K; Kwon IC; Oh YK; Shim CK
    J Gene Med; 2009 Sep; 11(9):791-803. PubMed ID: 19569085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maltose- and maltotriose-modified, hyperbranched poly(ethylene imine)s (OM-PEIs): Physicochemical and biological properties of DNA and siRNA complexes.
    Höbel S; Loos A; Appelhans D; Schwarz S; Seidel J; Voit B; Aigner A
    J Control Release; 2011 Jan; 149(2):146-58. PubMed ID: 20946922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. siRNA function in RNAi: a chemical modification analysis.
    Chiu YL; Rana TM
    RNA; 2003 Sep; 9(9):1034-48. PubMed ID: 12923253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical modifications on siRNAs avoid Toll-like-receptor-mediated activation of the hepatic immune system in vivo and in vitro.
    Broering R; Real CI; John MJ; Jahn-Hofmann K; Ickenstein LM; Kleinehr K; Paul A; Gibbert K; Dittmer U; Gerken G; Schlaak JF
    Int Immunol; 2014 Jan; 26(1):35-46. PubMed ID: 24065781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyethylenimines for siRNA and miRNA delivery in vivo.
    Höbel S; Aigner A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):484-501. PubMed ID: 23720168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymers in the Delivery of siRNA for the Treatment of Virus Infections.
    Reynolds N; Dearnley M; Hinton TM
    Top Curr Chem (Cham); 2017 Apr; 375(2):38. PubMed ID: 28324594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polyethylenimine (PEI)/siRNA-mediated gene knockdown in vitro and in vivo.
    Höbel S; Aigner A
    Methods Mol Biol; 2010; 623():283-97. PubMed ID: 20217558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model.
    Ewe A; Höbel S; Heine C; Merz L; Kallendrusch S; Bechmann I; Merz F; Franke H; Aigner A
    Drug Deliv Transl Res; 2017 Apr; 7(2):206-216. PubMed ID: 27334279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multifunctional pH-Sensitive Amino Lipids for siRNA Delivery.
    Gujrati M; Vaidya A; Lu ZR
    Bioconjug Chem; 2016 Jan; 27(1):19-35. PubMed ID: 26629982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic pharmacology: progresses in siRNA delivery and therapeutic applications.
    Scherman D; Rousseau A; Bigey P; Escriou V
    Gene Ther; 2017 Mar; 24(3):151-156. PubMed ID: 28121307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A retro-inverso cell-penetrating peptide for siRNA delivery.
    Vaissière A; Aldrian G; Konate K; Lindberg MF; Jourdan C; Telmar A; Seisel Q; Fernandez F; Viguier V; Genevois C; Couillaud F; Boisguerin P; Deshayes S
    J Nanobiotechnology; 2017 Apr; 15(1):34. PubMed ID: 28454579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymers for siRNA delivery: inspired by viruses to be targeted, dynamic, and precise.
    Wagner E
    Acc Chem Res; 2012 Jul; 45(7):1005-13. PubMed ID: 22191535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of Gold Nanoparticles for Gene Silencing.
    Tortiglione C; de la Fuente JM
    Methods Mol Biol; 2019; 1974():203-214. PubMed ID: 31099005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. siRNA conjugate delivery systems.
    Jeong JH; Mok H; Oh YK; Park TG
    Bioconjug Chem; 2009 Jan; 20(1):5-14. PubMed ID: 19053311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient and targeted delivery of siRNA in vivo.
    Shim MS; Kwon YJ
    FEBS J; 2010 Dec; 277(23):4814-27. PubMed ID: 21078116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene silencing mediated by small interfering RNAs in mammalian cells.
    Scherr M; Morgan MA; Eder M
    Curr Med Chem; 2003 Feb; 10(3):245-56. PubMed ID: 12570711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanotechnology As Potential Tool for siRNA Delivery in Parkinson's Disease.
    Cortes H; Alcala-Alcala S; Avalos-Fuentes A; Mendoza-Munoz N; Quintanar-Guerrero D; Leyva-Gomez G; Floran B
    Curr Drug Targets; 2017 Nov; 18(16):1866-1879. PubMed ID: 28325145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.